XTMAB 18
Alternative Names: XTMAB-18Latest Information Update: 29 Apr 2021
At a glance
- Originator Xentria
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified
Most Recent Events
- 24 Mar 2021 Early research in Unspecified in USA (unspecified route), prior to March 2021 (Xentria pipeline, March 2021)